SINUPHANT
DEAD

Serial Number

77863052

Owner

BIONORICA AG

Attorney

Kenneth F. Florek

Filing Date

Nov 2, 2009

Add to watchlist:

No watchlists yet
View on USPTO

SINUPHANT Trademark

Serial Number: 77863052

SINUPHANT is a trademark filed by BIONORICA AG on November 2, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 28 (Toys & Sporting Goods). The application is currently no longer active.

Owner Contact Info

BIONORICA AG (65 trademarks)

KERSCHENSTEINERSTRASSE 11-15
92318 NEUMARKT , DE

Entity Type: 09

Trademark Details

Filing Date

November 2, 2009

Registration Date

Not Registered

Published for Opposition

April 13, 2010

Goods & Services

Downloadable electronic publications in the nature of magazines, journals, newsletters, periodicals, catalogues, brochures, manuals, leaflets, package inserts in the field of medicine and phytopharmacy; downloadable electronic publications in the nature of press releases featuring information on medicine and phytopharmacy; pre-recorded magnetic data carriers featuring medicine and phytopharmacy; small weighing, measuring, signalling, checking and supervision apparatus, namely, pocket calculators, scales, balances, measuring rules, thermometers, computer storage devices, namely, flash drives, flash memory cards, memory cards and computer memory hardware to be used as an advertising medium; spectacles, namely, eyeglasses and goggles; protective helmets, namely, bicycle helmets; personal computers; DVD, CD, magnetic-tape recorders and players

Games and playthings, namely, board games, card games, dice games, memory games, party games, action skill games, dolls and puppets; positionable toy figures; gymnastic and sporting articles, namely, treadmills, stair machines, stationary exercise bikes, trampolines, skipping ropes, soccer balls, tennis balls, racket balls; rubber balls for games; hockey pucks, rackets; paddles for use in paddle ball games; decorations for Christmas trees, except lighting apparatus and confectionery

Pharmaceutical preparations for use in the treatment, cure, mitigation or prevention of gingivitis, halitosis, stomatitis, periodontitis, inflammation of the oral cavity and pharyngeal cavity, hypersensitivity of teeth, angina, atherosclerosis, bronchial asthma, circulatory disorders, constipation, diarrhoea, heart failure, heart rhythm disorders, high blood pressure, indigestion, insomnia, migraine, motion sickness, nausea, peptic ulcers, vomiting, allergy, gynaecological disorders affecting menstruation, sterility, menstrual syndromes, dysmenorrhoea, infertility, genital tract infections, pelvic inflammatory diseases, vaginal discomfort due to menopausal atrophic changes, anatomical abnormalities of the head, the extremities, chest, abdomen and organs, neoplasia, breast neoplasm, breast cancer, mamma carcinoma, mastopathy, mastodynia, premenstrual syndrome, climateric complaints, breast pain, blood conditions and disorders, blood circulation disorders, high blood pressure, hypertension, pulmonary diseases, heart rhythm disorders, heart failure, urological diseases, sexually transmitted diseases and inflammatory pelvic diseases, menopausal complaints due to therapeutically induced menopause, tamoxifen induced hot flushes of breast cancer survivors, climactic sleep disturbances, depressive moods, protection of the skeletal system, osteoporosis, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, psycho vegetative disorders, depressive syndrome, anxiety, nervous unrest, peripheral nervous system infections, peripheral nervous system movement disorders, nerve compression syndromes, neuritis, neuralgia and regional pain syndromes, diseases and disorders of the kidney, urological disorders, chronic infections of the bladder, cystitis, pyelonephritis, glomerulonephritis, interstitial nephritis, neprholithiasis, cancer, urolith prophylaxis, dizziness, migraine, depression, inflammations of the upper and lower respiratory organs, sinuses, bronchitis, tonsillitis, arthritis, osteoarthritis, fever, cough, cold, Alzheimer's disease, infection of respiratory tract, infection of urinary tract, urinary obstruction, chronic venous insufficiency, prostate hyperplasia, muscle pains, soft tissue rheumatism, musculoskeletal disease, liver disease, hepatitis, cirrhosis of liver, periodontal diseases and dental caries; pharmaceutical preparations for use as an antidepressant, diuretic, hypnotic, sedative, analeptic, and tranquilizer; haemorrhoidal ointment, laxative, nasal decongestant capsules, nasal spray preparations, non-narcotic analgesics, throat lozenges; medicinal preparations in tablet form, namely, menstruation circulation regulating tablets; pharmaceutical preparations, namely, for hormone regulation and hormone replacement; pharmaceutical preparations for sensory organs, namely, for use in ophthalmology, otolaryngology and dermatology; pharmaceutical preparations for regulation and strengthening of the immune system; pharmaceutical preparations for treating of and providing temporary relief for occasional minor irritation, pain, sore mouth, sore gums, sore throat, pain associated with canker sores, pain due to minor irritation or injury of the mouth and gums, pain due to minor dental procedures, pain due to minor irritations caused by dentures or orthodontic appliances, sore gums due to teething in infants and children four months of age and older; pharmaceutical products, namely, medicated dental, gum and mouth washes, medicated dental, gum and mouth rinse, medicated toothpastes, medicated oral-care gels, medicated dental gels, medicated lozenges, cough lozenges, medicated chewing gum, medicated gels and fluids in the nature of dental bleaching gels, gum balms, medicated dental floss, medicated dental tapes, medicated dental ribbons, medicated teeth whitener gels, medicated toothpicks, fluoride chewing gum and chewable tablets for disclosing dental plaque and tartar; pharmaceutical preparations for dental purposes, namely, plaque disclosing reagents, periodontal diagnostic reagents for medical purposes for detecting derivatives from periodontal bacteria, caries, diagnostic reagents for detecting derivatives from caries-causing bacteria and medicines for the prevention and treatment of periodontal diseases, dental caries, canker sores, cold sores, mucositis and oral and tongue cancers; medicated mouth sprays and desensitizers; plant extracts for veterinary and pharmaceutical purposes; sanitary preparations for medical use; sanitary preparations for hygiene, namely, antiseptics, oral antiseptics, disinfectants for hygiene purposes; sanitary preparations for the treatment, cleaning and protection of the skin; dietetic foods adapted for medical use in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; food for medically restricted diets, food for diabetics, food supplements containing plant extracts, food supplements derived from plants or plant extracts, all aforesaid goods in the form of tablets, drops, capsules, extract preparations, balms or in liquid form; vitamin and mineral supplements; food supplements, namely, herbal teas for medicinal purposes and medicinal teas; nutritional additives for medicinal purposes for use in foods and dietary supplements for human consumption; dietetic food supplements; dietary supplements; food supplements and dietary food supplements; mineral food supplements, food supplements based on amino acids, minerals and/or trace elements; dietary supplements; food supplements and dietary food supplements; plant extracts for pharmaceutical purposes; medical plasters; materials for dressings, namely, gauze and bandages; all purpose disinfectants; material for stopping teeth; dental wax

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 9, 2012 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 9, 2012 ABN6
CORRECTED NOA E-MAILED
Feb 16, 2012 NOAC
DIVISIONAL PROCESSING COMPLETE
Feb 14, 2012 DPCC
DIVISIONAL REQUEST RECEIVED
Jan 24, 2012 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Jan 24, 2012 ERTD
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
Jan 24, 2012 UNTD
TEAS REQUEST TO DIVIDE RECEIVED
Jan 4, 2012 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 31, 2011 EXRA
SOU EXTENSION 3 GRANTED
Dec 30, 2011 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 30, 2011 AITU
SOU EXTENSION 3 FILED
Dec 6, 2011 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 6, 2011 EEXT
ASSIGNED TO EXAMINER
Aug 8, 2011 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2011 EXRA
SOU EXTENSION 2 GRANTED
Jun 7, 2011 EX2G
SOU EXTENSION 2 FILED
Jun 7, 2011 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 7, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 8, 2010 EXRA
SOU EXTENSION 1 GRANTED
Dec 6, 2010 EX1G
SOU EXTENSION 1 FILED
Dec 6, 2010 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 6, 2010 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 23, 2010 TCCA
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 8, 2010 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 13, 2010 NPUB
PUBLISHED FOR OPPOSITION
Apr 13, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 9, 2010 PREV
ASSIGNED TO LIE
Mar 9, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 17, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 17, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 17, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 17, 2010 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 12, 2010 GPRN
PRIORITY ACTION E-MAILED
Feb 12, 2010 GPRA
PRIORITY ACTION WRITTEN
Feb 12, 2010 CPRA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 8, 2010 GPRN
PRIORITY ACTION E-MAILED
Feb 8, 2010 GPRA
PRIORITY ACTION WRITTEN
Feb 8, 2010 CPRA
ASSIGNED TO EXAMINER
Feb 5, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 5, 2009 NWOS
NEW APPLICATION ENTERED
Nov 5, 2009 NWAP